Zhong, M. Et Al. 2022. Prediction of multiple sclerosis outcomes when switching to ocrelizumab. MULTIPLE SCLEROSIS JOURNAL , vol.28, no.6 , 958-969.

Zhong, M., van der Walt, A., Stankovich, J., Kalincik, T., Buzzard, K., Skibina, O., ... BOZ, C.(2022). Prediction of multiple sclerosis outcomes when switching to ocrelizumab. MULTIPLE SCLEROSIS JOURNAL , vol.28, no.6, 958-969.

Zhong, Michael Et Al. "Prediction of multiple sclerosis outcomes when switching to ocrelizumab," MULTIPLE SCLEROSIS JOURNAL , vol.28, no.6, 958-969, 2022

Zhong, Michael Et Al. "Prediction of multiple sclerosis outcomes when switching to ocrelizumab." MULTIPLE SCLEROSIS JOURNAL , vol.28, no.6, pp.958-969, 2022

Zhong, M. Et Al. (2022) . "Prediction of multiple sclerosis outcomes when switching to ocrelizumab." MULTIPLE SCLEROSIS JOURNAL , vol.28, no.6, pp.958-969.

@article{article, author={Michael Zhong Et Al. }, title={Prediction of multiple sclerosis outcomes when switching to ocrelizumab}, journal={MULTIPLE SCLEROSIS JOURNAL}, year=2022, pages={958-969} }